… Renal fibrosis is the final pathological process common to any ongoing, chronic kidney … It
is considered as the underlying pathological process of chronic kidney disease (CKD), which …

… renal fibrosis as we elucidated above, and thus, targeting OS seems to be a promising strategy
in renal fibrosis … CKD progression by reducing renal fibrosis in preclinical or clinical trials. …

… Furthermore, a better understanding of renal fibrosis is also favored to discover biomarkers
of fibrotic injury. In the review, we update recent advances in the mechanism of renal fibrosis …

… demonstrating their importance for kidney disease (Buhl … renal fibrosis. While PDGF-C
deficiency or antagonism failed to protect from liver fibrosis, the lack of PDGF-C prevented kidney …

… in renal fibrosis. In this section, we will discuss how mesangial cells are activated and its
contributions to renal fibrosis, as well as the molecular mechanisms and novel anti-fibrotic …

… , the detailed molecular mechanisms still need … molecules will be defined in the future, which
is beneficial for developing the novel therapeutic strategies for the treatment of renal fibrosis …

… In this review, we will discuss the major cellular and molecular mechanisms underlying the
regression of fibrosis/cirrhosis and the potential therapeutic approaches aimed at reversing …

… kidney remains controversial. Collectively, understanding … cell functions and mechanisms
during renal fibrosis is paramount to improving diagnosis and treatment of chronic kidney …

… of renal fibrosis. Moreover, the cellular and molecular mechanisms mediating fibrosis are still
not … of the complex mechanisms and related cellular mediators of kidney fibrosis is urgently …

… fibrosis in the transition from AKI to CKD and highlight that progressive renal fibrosis requires
… primary interstitial disease is itself the triggering factor for fibrosis [23,77]. Recently, in a …